WU polyomavirus

Last updated
Human polyomavirus 4
Virus classification OOjs UI icon edit-ltr.svg
(unranked): Virus
Realm: Monodnaviria
Kingdom: Shotokuvirae
Phylum: Cossaviricota
Class: Papovaviricetes
Order: Sepolyvirales
Family: Polyomaviridae
Genus: Betapolyomavirus
Species:
Human polyomavirus 4

WU polyomavirus (also known as WU virus, WUPyV, or Human polyomavirus 4) is a virus of the family Polyomaviridae. It was discovered in 2007 in samples of human respiratory secretions, originally from a child patient in Australia who presented with clinical signs of pneumonia and in whom other common respiratory viruses were not detected. Follow-up studies identified the presence of WU virus in respiratory secretion samples from patients in Australia and the United States, suggesting that, like other human polyomaviruses, WU virus is widely distributed. [1]

Contents

Discovery

WU virus was discovered by shotgun sequencing of the nucleic acids found in the respiratory secretions of a young patient diagnosed with pneumonia in whom other known respiratory viruses had not been detected. Sequence homology was detected among the sequences found in the clinical sample and the known genomes of other human polyomaviruses. [1] WU virus was one of two new human polyomaviruses discovered in 2007; the other was KI virus. [2]

Genome

Genome structure of the WU virus. Gaynor plospathogens 2007 WUvirusgenome.png
Genome structure of the WU virus.

The complete genome of the WU virus has been sequenced and found to be a circular double-stranded DNA genome of 5229 base pairs containing genetic material characteristic of polyomaviruses, encoding five viral proteins: three capsid components, major capsid protein VP1, VP2, and VP3; and two additional proteins involved in replication, the large tumor antigen and small tumor antigen. [1]

Prevalence

Although WU virus has been detected in a variety of locations around the world, indicating a global distribution, estimates of its prevalence vary. In the first report describing the virus, its DNA was detected in 0.7% of respiratory secretion samples in a population in St. Louis, Missouri and 3.0% of samples in Brisbane, Australia. [1] Similar prevalence rates under 5% have been reported in various locations and populations, with some indication of age-dependence. [3] By contrast, one 2009 study placed seroprevalence - that is, prevalence of antibodies against the virus (in this case the VP1 coat protein) - as high as 69% among a population of American adults and 54% among a population of American children. [4] Another 2009 study found around 80% seroprevalence for adults, with age patterns indicating that infants may inherit maternal antibodies against both WU and KI. [5] A 2016 study of polyomavirus seroprevalence found WU virus in 97.4% of samples from another American population. [6] Primary infection is generally believed to occur in childhood. [6]

Disease association

WU virus was originally discovered in respiratory secretions from a patient diagnosed with pneumonia of unknown origin. [1] However, the overall rate of co-infection with other respiratory viruses is high, [1] [3] and it is not clear that WU virus itself causes disease. [7] WU virus has not been detected in urine, [1] although many polyomaviruses infect the kidneys and urinary tract and one human polyomavirus, BK virus, is associated with nephropathy in renal transplant patients. [8] Some polyomaviruses are well known as carcinogenic, including the human polyomavirus Merkel cell polyomavirus, but WU virus has also not been associated with cancer. [9] While no clear association with clinical symptoms has been identified, there is weak indication that WU and KI viruses may have pathogenic potential in immunocompromised patients. [10]

Nomenclature and classification

WU virus got its name from Washington University in St. Louis, the institutional affiliation of the researchers who discovered and reported the virus. [1] As originally described, WU virus was most similar to KI virus and somewhat divergent from the other human polyomaviruses known at the time, JC virus and BK virus. A 2010 proposed classification recommended the division of the polyomaviruses into three genera, containing one genus of avian viruses and two of mammalian viruses; one of the latter was designated Wukipolyomavirus to indicate its two founding members. [11] In an updated classification system for the polyomavirus family proposed in 2016, WU virus is classified as a member of the genus Betapolyomavirus along with BK, JC, and KI. [8]

Related Research Articles

<i>Polyomaviridae</i> Family of viruses

Polyomaviridae is a family of viruses whose natural hosts are primarily mammals and birds. As of 2020, there are six recognized genera and 117 species, five of which are unassigned to a genus. 14 species are known to infect humans, while others, such as Simian Virus 40, have been identified in humans to a lesser extent. Most of these viruses are very common and typically asymptomatic in most human populations studied. BK virus is associated with nephropathy in renal transplant and non-renal solid organ transplant patients, JC virus with progressive multifocal leukoencephalopathy, and Merkel cell virus with Merkel cell cancer.

Merkel cell polyomavirus was first described in January 2008 in Pittsburgh, Pennsylvania. It was the first example of a human viral pathogen discovered using unbiased metagenomic next-generation sequencing with a technique called digital transcriptome subtraction. MCV is one of seven currently known human oncoviruses. It is suspected to cause the majority of cases of Merkel cell carcinoma, a rare but aggressive form of skin cancer. Approximately 80% of Merkel cell carcinoma (MCC) tumors have been found to be infected with MCV. MCV appears to be a common—if not universal—infection of older children and adults. It is found in respiratory secretions, suggesting that it might be transmitted via a respiratory route. However, it has also been found elsewhere, such as in shedded healthy skin and gastrointestinal tract tissues, thus its precise mode of transmission remains unknown. In addition, recent studies suggest that this virus may latently infect the human sera and peripheral blood mononuclear cells.

<span class="mw-page-title-main">Trichodysplasia spinulosa</span> Medical condition

Trichodysplasia spinulosa is a rare cutaneous condition that has been described almost exclusively in immunocompromised patients, usually organ transplant recipients, on regimens of immunosuppressive drugs. As of early 2016, a total of 32 cases had been reported in the medical literature. Despite its rarity, TS is believed to be underdiagnosed, and the growing population of patients on immunosuppressive drug regimens suggests its incidence may rise. TS has been described as an emerging infectious disease.

Trichodysplasia spinulosa polyomavirus is a member virus of Human polyomavirus 8 that infects human hosts. First discovered in 2010, TSPyV is associated with Trichodysplasia spinulosa, a rare skin disease only seen in immunocompromised patients. The virus causes hyperproliferation and enlargement of hair follicles by modulating PP2A protein phosphatase signaling pathways. TSPyV was the eighth human polyomavirus to be discovered, and one of four associated with human disease, out of 13 human polyomaviruses known as of the 2015 update to polyomavirus taxonomy released by the International Committee on Taxonomy of Viruses.

<span class="mw-page-title-main">Murine polyomavirus</span> Species of virus

Murine polyomavirus is an unenveloped double-stranded DNA virus of the polyomavirus family. The first member of the family discovered, it was originally identified by accident in the 1950s. A component of mouse leukemia extract capable of causing tumors, particularly in the parotid gland, in newborn mice was reported by Ludwik Gross in 1953 and identified as a virus by Sarah Stewart and Bernice Eddy at the National Cancer Institute, after whom it was once called "SE polyoma". Stewart and Eddy would go on to study related polyomaviruses such as SV40 that infect primates, including humans. These discoveries were widely reported at the time and formed the early stages of understanding of oncoviruses.

<span class="mw-page-title-main">Major capsid protein VP1</span>

Major capsid protein VP1 is a viral protein that is the main component of the polyomavirus capsid. VP1 monomers are generally around 350 amino acids long and are capable of self-assembly into an icosahedral structure consisting of 360 VP1 molecules organized into 72 pentamers. VP1 molecules possess a surface binding site that interacts with sialic acids attached to glycans, including some gangliosides, on the surfaces of cells to initiate the process of viral infection. The VP1 protein, along with capsid components VP2 and VP3, is expressed from the "late region" of the circular viral genome.

Aichivirus A formerly Aichi virus (AiV) belongs to the genus Kobuvirus in the family Picornaviridae. Six species are apart of the genus Kobuvirus, Aichivirus A-F. Within Aichivirus A, there are six different types including human Aichi virus, canine kobuvirus, murine kobuvirus, Kathmandu sewage kobuvirus, roller kobuvirus, and feline kobuvirus. Three different genotypes are found in human Aichi virus, represented as genotype A, B, and C.

Hamster polyomavirus is an unenveloped double-stranded DNA virus of the polyomavirus family whose natural host is the hamster. It was originally described in 1967 by Arnold Graffi as a cause of epithelioma in Syrian hamsters.

KI polyomavirus is a virus of the family Polyomaviridae. It was discovered in 2007 in stored samples of human respiratory secretions collected by the Karolinska Institute, after which the virus is named.

<span class="mw-page-title-main">Agnoprotein</span> Viral protein found in some polyomaviruses

Agnoprotein is a protein expressed by some members of the polyomavirus family from a gene called the agnogene. Polyomaviruses in which it occurs include two human polyomaviruses associated with disease, BK virus and JC virus, as well as the simian polyomavirus SV40.

Human polyomavirus 7 (HPyV7) is a virus of the polyomavirus family that infects human hosts. It was discovered in 2010 and is a common component of the skin flora in healthy adults. There is limited evidence from case reports linking the virus to a skin rash occurring in immunocompromised organ transplant recipients.

Human polyomavirus 6 (HPyV6) is a virus of the polyomavirus family that infects human hosts. It was discovered in 2010 and is a component of the skin flora in healthy adults.

Human polyomavirus 9 (HPyV9) is a virus of the polyomavirus family that infects human hosts. It was discovered in 2011 and is a component of the skin flora in healthy adults.

Sorex araneus polyomavirus 1, formerly known as Human polyomavirus 12 (HPyV12), is a virus of the polyomavirus family that was first identified in human hosts and also infects shrews. It was discovered and reported in 2013 after isolation from the organs of the gastrointestinal tract, particularly the liver. The virus was renamed to Sorex araneus polyomavirus 1 in 2018, after discovery of the same virus in shrews. Infecting multiple hosts is rare among mammalian polyomaviruses.

MW polyomavirus is a virus of the polyomavirus family that infects human hosts. It was discovered in 2012 and reported independently by several research groups. It has been identified mostly in stool samples from children and has been detected in a variety of geographic locations.

STL polyomavirus is a virus of the polyomavirus family that infects human hosts. It was first reported in 2013 and is most closely related to MW polyomavirus. It has been identified mostly in stool samples from children and has been detected in a variety of geographic locations.

New Jersey polyomavirus is a virus of the polyomavirus family that infects human hosts. It was first identified in 2014 in a pancreatic transplant patient in New Jersey. It is the 13th and most recent human polyomavirus to be described.

<span class="mw-page-title-main">Large tumor antigen</span>

The large tumor antigen is a protein encoded in the genomes of polyomaviruses, which are small double-stranded DNA viruses. LTag is expressed early in the infectious cycle and is essential for viral proliferation. Containing four well-conserved protein domains as well as several intrinsically disordered regions, LTag is a fairly large multifunctional protein; in most polyomaviruses, it ranges from around 600-800 amino acids in length. LTag has two primary functions, both related to replication of the viral genome: it unwinds the virus's DNA to prepare it for replication, and it interacts with proteins in the host cell to dysregulate the cell cycle so that the host's DNA replication machinery can be used to replicate the virus's genome. Some polyomavirus LTag proteins - most notably the well-studied SV40 large tumor antigen from the SV40 virus - are oncoproteins that can induce neoplastic transformation in the host cell.

<span class="mw-page-title-main">Small tumor antigen</span>

The small tumor antigen is a protein encoded in the genomes of polyomaviruses, which are small double-stranded DNA viruses. STag is expressed early in the infectious cycle and is usually not essential for viral proliferation, though in most polyomaviruses it does improve replication efficiency. The STag protein is expressed from a gene that overlaps the large tumor antigen (LTag) such that the two proteins share an N-terminal DnaJ-like domain but have distinct C-terminal regions. STag is known to interact with host cell proteins, most notably protein phosphatase 2A (PP2A), and may activate the expression of cellular proteins associated with the cell cycle transition to S phase. In some polyomaviruses - such as the well-studied SV40, which natively infects monkeys - STag is unable to induce neoplastic transformation in the host cell on its own, but its presence may increase the transforming efficiency of LTag. In other polyomaviruses, such as Merkel cell polyomavirus, which causes Merkel cell carcinoma in humans, STag appears to be important for replication and to be an oncoprotein in its own right.

Minor capsid protein VP2 and minor capsid protein VP3 are viral proteins that are components of the polyomavirus capsid. Polyomavirus capsids are composed of three proteins; the major component is major capsid protein VP1, which self-assembles into pentamers that in turn self-assemble into enclosed icosahedral structures. The minor components are VP2 and VP3, which bind in the interior of the capsid.

References

  1. 1 2 3 4 5 6 7 8 9 Gaynor, AM; Nissen, MD; Whiley, DM; Mackay, IM; Lambert, SB; Wu, G; Brennan, DC; Storch, GA; Sloots, TP; Wang, D (4 May 2007). "Identification of a novel polyomavirus from patients with acute respiratory tract infections". PLOS Pathogens. 3 (5): e64. doi: 10.1371/journal.ppat.0030064 . PMC   1864993 . PMID   17480120.
  2. Allander, Tobias; Andreasson, Kalle; Gupta, Shawon; Bjerkner, Annelie; Bogdanovic, Gordana; Persson, Mats A. A.; Dalianis, Tina; Ramqvist, Torbjörn; Andersson, Björn (2007-04-01). "Identification of a third human polyomavirus". Journal of Virology. 81 (8): 4130–4136. doi:10.1128/JVI.00028-07. ISSN   0022-538X. PMC   1866148 . PMID   17287263.
  3. 1 2 Abedi Kiasari, B; Vallely, PJ; Corless, CE; Al-Hammadi, M; Klapper, PE (September 2008). "Age-related pattern of KI and WU polyomavirus infection". Journal of Clinical Virology. 43 (1): 123–5. doi:10.1016/j.jcv.2008.05.003. PMC   7108349 . PMID   18573691.
  4. Kean, JM; Rao, S; Wang, M; Garcea, RL (March 2009). "Seroepidemiology of human polyomaviruses". PLOS Pathogens. 5 (3): e1000363. doi: 10.1371/journal.ppat.1000363 . PMC   2655709 . PMID   19325891.
  5. Nguyen, Nang L.; Le, Binh Minh; Wang, David (2009-08-01). "Serologic evidence of frequent human infection with WU and KI polyomaviruses". Emerging Infectious Diseases. 15 (8): 1199–1205. doi:10.3201/eid1508.090270. ISSN   1080-6059. PMC   2815979 . PMID   19751580.
  6. 1 2 Gossai, A; Waterboer, T; Nelson, HH; Michel, A; Willhauck-Fleckenstein, M; Farzan, SF; Hoen, AG; Christensen, BC; Kelsey, KT; Marsit, CJ; Pawlita, M; Karagas, MR (1 January 2016). "Seroepidemiology of Human Polyomaviruses in a US Population". American Journal of Epidemiology. 183 (1): 61–9. doi:10.1093/aje/kwv155. PMC   5006224 . PMID   26667254.
  7. Norja, P; Ubillos, I; Templeton, K; Simmonds, P (December 2007). "No evidence for an association between infections with WU and KI polyomaviruses and respiratory disease". Journal of Clinical Virology. 40 (4): 307–11. doi:10.1016/j.jcv.2007.09.008. PMC   7172997 . PMID   17997354.
  8. 1 2 Polyomaviridae Study Group of the International Committee on Taxonomy of, Viruses; Calvignac-Spencer, S; Feltkamp, MC; Daugherty, MD; Moens, U; Ramqvist, T; Johne, R; Ehlers, B (June 2016). "A taxonomy update for the family Polyomaviridae". Archives of Virology. 161 (6): 1739–50. doi: 10.1007/s00705-016-2794-y . hdl: 10037/13151 . PMID   26923930.
  9. Dalianis, T; Hirsch, HH (15 March 2013). "Human polyomaviruses in disease and cancer". Virology. 437 (2): 63–72. doi: 10.1016/j.virol.2012.12.015 . PMID   23357733.
  10. Babakir-Mina, M; Ciccozzi, M; Perno, CF; Ciotti, M (August 2013). "The human polyomaviruses KI and WU: virological background and clinical implications". APMIS . 121 (8): 746–54. doi: 10.1111/apm.12091 . PMID   23782405. S2CID   38133334.
  11. Johne, R; Buck, CB; Allander, T; Atwood, WJ; Garcea, RL; Imperiale, MJ; Major, EO; Ramqvist, T; Norkin, LC (September 2011). "Taxonomical developments in the family Polyomaviridae". Archives of Virology. 156 (9): 1627–34. doi:10.1007/s00705-011-1008-x. PMC   3815707 . PMID   21562881.